Drug resistance, epigenetics, and tumor cell heterogeneity
- PMID: 20410528
- DOI: 10.1126/scitranslmed.3001056
Drug resistance, epigenetics, and tumor cell heterogeneity
Abstract
The resistance of cancer cells to various therapeutic agents and modalities is a crucial issue in clinical oncology. A recent Cell paper highlights how changes at the chromatin level control drug sensitivity and provides insight into more effective strategies for treating cancer with combination therapies.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
